[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370698-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370698-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","combining-spatial-transcriptomics-pseudotime-and-machine-learning-enables-discovery-of-biomarkers-for-prostate-cancer-diagnostic-potential","Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer - Diagnostic Potential","","Early cancer diagnosis is crucial but challenging due to limited biomarkers that can be measured with routine clinical methods. Biomarker discovery is difficult because tumors undergo complex, patient-specific and within-tumor changes across thousands of genes. The study hypothesizes reliable, routinely measurable biomarkers by integrating spatial transcriptomics across malignant grades, modeling molecular changes with pseudotime, and prioritizing genes via machine-learning using prostate cancer datasets. Identified markers were linked to grade, copy-number aberrations, pathways, and drug targets, including strong urine performance (AUC 0.92), supporting diagnostic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/combining-spatial-transcriptomics-pseudotime-and-machine-learning-enables-discovery-of-biomarkers-for-prostate-cancer-diagnostic-potential/370698/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/combining-spatial-transcriptomics-pseudotime-and-machine-learning-enables-discovery-of-biomarkers-for-prostate-cancer-diagnostic-potential/370698.png","ImageObject",300,407,{"name":42,"@type":43},"Rizky","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are reliable early prostate cancer biomarkers hard to obtain with routine clinical tests?","Question",{"text":63,"@type":64},"Early detection is limited by the lack of reliable biomarkers that are measurable using routine clinical methods. Tumors also show complex gene-interaction changes that vary by patient and even within the same tumor.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What three data-driven components does the study combine to discover biomarkers?",{"text":68,"@type":64},"The approach integrates spatial transcriptomics, pseudotime models of malignant transformation, and machine-learning models to prioritize genes correlated with transformation and predict cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"How were the candidate biomarkers validated for prostate cancer relevance?",{"text":72,"@type":64},"The identified genes were associated with cancer grade, copy-number aberrations, hallmark pathways, and drug targets, and they were evaluated as biomarkers using mRNA, IHC, and proteomics data from patient-related samples and controls.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370698,1790706814,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer  \nMartin Smelik1, Daniel Diaz-Roncero Gonzalez1, Xiaojing An2, Rakesh Heer3, Lars Henningsohn1, Xinxiu Li1, Hui Wang4, Yelin Zhao1, and Mikael Benson1  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Early cancer diagnosis is crucial but challenging owing to the lack of reliable biomarkers that can be measured using routine clinical methods. The identification of biomarkers for early detection is complicated by each tumor involving changes in the interactions between thousands of genes. In addition to this staggering complexity, these interactions can vary among patients with the same diagnosis as well as within the same tumor. We hypothesized that reliable biomarkers that can be measured with routine methods could be identified by exploiting three facts: (i) the same tumor can have multiple grades of malignant transformation; (ii) these grades and their molecular changes can be characterized using spatial transcriptomics; and (iii) these changes can be integrated into models of malignant transformation using pseudotime. Pseudotime models were constructed based on spatial transcriptomic data from three independent prostate cancer studies to prioritize the genes that were most correlated with malignant transformation. The identified genes were associated with cancer grade, copynumber aberrations, hallmark pathways, and drug targets, and they encoded candidate biomarkers for prostate cancer in mRNA, IHC, and proteomics data from the sera, prostate tissue, and urine of more than 2,000 patients with prostate cancer and controls. Machine learning– based prediction models revealed that the biomarkers in urine had an AUC of 0.92 for prostate cancer and were associated with cancer grade. Overall, this study demonstrates the diagnostic potential of combining spatial transcriptomics, pseudotime, and machine learning for prostate cancer, which should be further tested in prospective studies.\u003Cbr>Significance: Integrating spatial transcriptomics, pseudotime, and machine learning analyses is effective for identifying prostate\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | cancer biomarkers that are reliable in different settings and measurable with routine methods, providing potential early diagnosis strategies.\u003Cbr>\u003Cbr>Spatial analysis of prostate cancer samples\u003Cbr>Pseudotime computation and gene prioritization Malignant Transformations\u003Cbr>Pseudotime\u003Cbr>HPC genes\u003Cbr>HNC genes\u003Cbr>Prediction models\u003Cbr>Cancer prediction\u003Cbr>HPC proteins\u003Cbr>HNC proteins\u003Cbr>Severity prediction\u003Cbr>Created in BioRender. Smelik, M. (2025) [https://BioRender.com/k79g739](https://BioRender.com/k79g739) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nThis article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.  \nIntroduct","cbCaitaZPfnuBmJz","https://ap.wps.com/l/cbCaitaZPfnuBmJz","pdf",31942884,13,"English","# Introduction\n## Early diagnosis challenges and biomarker limitations\n## Study hypothesis and integrated computational strategy\n# Methods overview\n## Spatial transcriptomics across prostate cancer studies\n## Pseudotime modeling for malignant transformation\n## Gene prioritization and prediction modeling\n# Results overview\n## Biomarker associations across grade and molecular features\n## Urine-based biomarker prediction performance\n# Significance","[{\"question\":\"Why are reliable early prostate cancer biomarkers hard to obtain with routine clinical tests?\",\"answer\":\"Early detection is limited by the lack of reliable biomarkers that are measurable using routine clinical methods. Tumors also show complex gene-interaction changes that vary by patient and even within the same tumor.\"},{\"question\":\"What three data-driven components does the study combine to discover biomarkers?\",\"answer\":\"The approach integrates spatial transcriptomics, pseudotime models of malignant transformation, and machine-learning models to prioritize genes correlated with transformation and predict cancer.\"},{\"question\":\"How were the candidate biomarkers validated for prostate cancer relevance?\",\"answer\":\"The identified genes were associated with cancer grade, copy-number aberrations, hallmark pathways, and drug targets, and they were evaluated as biomarkers using mRNA, IHC, and proteomics data from patient-related samples and controls.\"}]","Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer - Diagnostic Potential | PDF",1790189921,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc2dd8c1c620d48b19444debb2815d26.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b259efd5332ddd7e1178c39da4f288f0.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e15a595381267776b751ed2840d37fc.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6cb094877e5b297448bb89e79205793.webp",980,1311]